* Fields are mandatory
On likely weak exports, growth to be driven by farm income, GST reforms and government spending
Profit increases on steady growth in revenue amid challenges and stable input costs
Lower cost of deposits, the sharp 100 bps CRR cut, improving loan growth and stable Casa to aid margins improvement
Looks at non-US exports to escape from US tariffs
Expects strong execution in H2FY2026
Growth momentum to remain positive in Q2FY2026
Consumers prioritize health, convenience and quality
Extended monsoon and early Diwali impact sales
Refining margins likely to remain healthy
Large deal activity remains strong
Domestic prices turn soft in Q2FY2026
Hopes of cheaper credit in India and the US and cooling crude propel large- and mid-caps to record highs
Targeting high-potential therapeutic areas to drive growth
IPO is to fund store expansion and for marketing initiatives
For the best experience please go back to portrait mode.